JOP/2019/0049A
JOP20190049A1
(en)
|
2016-09-23 |
2017-06-16 |
Dopamine-?-hydroxylase inhibitors
|
JOP/2019/0050A
JOP20190050A1
(en)
|
2016-09-23 |
2017-06-16 |
Blood-brain barrier-penetrant dopamine-?-hydroxylase inhibitors
|
GBGB1713779.5A
GB201713779D0
(en)
|
2017-08-29 |
2017-08-29 |
Blood-brain barrier-penetrant dopamine B-hydroxylase inhibitors
|
UAA201904171A
UA123071C2
(en)
|
2016-09-23 |
2017-09-22 |
DOPAMINE-<font face="Symbol">b</font>-HYDROXYLASE INHIBITORS
|
CN201780056790.7A
CN109715633B
(en)
|
2016-09-23 |
2017-09-22 |
Dopamine-beta-hydroxylase inhibitors
|
BR112019004248A
BR112019004248A2
(en)
|
2016-09-23 |
2017-09-22 |
dopamine b-hydroxylase inhibitors
|
MA046273A
MA46273A
(en)
|
2016-09-23 |
2017-09-22 |
DOPAMINE- -HYDROXYLASE INHIBITORS PENETRATING THE HEMATOENCEPHALIC BARRIER
|
KR1020197010873A
KR20190080864A
(en)
|
2016-09-23 |
2017-09-22 |
Blood-brain barrier-permeable dopamine-beta -hydroxylase inhibitor
|
CN201780056801.1A
CN109715155A
(en)
|
2016-09-23 |
2017-09-22 |
Blood-brain barrier-penetrating agent dopamine-B-hydroxylase inhibitors
|
US16/335,529
US11034695B2
(en)
|
2016-09-23 |
2017-09-22 |
Dopamine-β-hydroxylase inhibitors
|
EA201990763A
EA201990763A1
(en)
|
2017-08-29 |
2017-09-22 |
DOPAMINE-B-HYDROXYLASE INHIBITORS penetrating through the blood-brain barrier
|
BR112019004254A
BR112019004254A2
(en)
|
2016-09-23 |
2017-09-22 |
blood-brain barrier penetrating dopamine-b-hydroxylase inhibitors
|
PCT/PT2017/050022
WO2018056854A1
(en)
|
2016-09-23 |
2017-09-22 |
Blood-brain barrier-penetrant dopamine-b-hydroxylase inhibitors
|
AU2017330174A
AU2017330174A1
(en)
|
2016-09-23 |
2017-09-22 |
Blood-brain barrier-penetrant dopamine-β-hydroxylase inhibitors
|
CA3037692A
CA3037692A1
(en)
|
2016-09-23 |
2017-09-22 |
Blood-brain barrier-penetrant dopamine-b-hydroxylase inhibitors
|
MX2019003310A
MX2019003310A
(en)
|
2016-09-23 |
2017-09-22 |
Dopamine-b-hydroxylase inhibitors.
|
SG11201901817SA
SG11201901817SA
(en)
|
2016-09-23 |
2017-09-22 |
Blood-brain barrier-penetrant dopamine-b-hydroxylase inhibitors
|
MA046280A
MA46280A
(en)
|
2016-09-23 |
2017-09-22 |
DOPAMINE-B-HYDROXYLASE INHIBITORS
|
MX2019003352A
MX2019003352A
(en)
|
2016-09-23 |
2017-09-22 |
Blood-brain barrier-penetrant dopamine-b-hydroxylase inhibitors.
|
JP2019515929A
JP2019529460A
(en)
|
2016-09-23 |
2017-09-22 |
Vascular brain barrier permeation agent dopamine-B-hydroxylase inhibitor
|
JP2019515915A
JP2019529459A
(en)
|
2016-09-23 |
2017-09-22 |
Dopamine-B-hydroxylase inhibitor
|
PCT/PT2017/050023
WO2018056855A1
(en)
|
2016-09-23 |
2017-09-22 |
Dopamine-b-hydroxylase inhibitors
|
UAA201904180A
UA125479C2
(en)
|
2016-09-23 |
2017-09-22 |
DOPAMINE-<font face="Symbol"></font>-HYDROXYLASE INHIBITORS THAT CROSS THE BLOOD-BRAIN BARRIER
|
AU2017330175A
AU2017330175B2
(en)
|
2016-09-23 |
2017-09-22 |
Dopamine-β-hydroxylase inhibitors
|
SG11201901850XA
SG11201901850XA
(en)
|
2016-09-23 |
2017-09-22 |
Dopamine-b-hydroxylase inhibitors
|
TW106132669A
TW201817713A
(en)
|
2016-09-23 |
2017-09-22 |
Blood-brain barrier-penetrant dopamine-[beta]-hydroxylase inhibitors
|
EA201990771A
EA201990771A1
(en)
|
2017-08-29 |
2017-09-22 |
DOPAMIN-β-HYDROXYLASE INHIBITORS
|
US16/335,521
US10975083B2
(en)
|
2016-09-23 |
2017-09-22 |
Blood-brain barrier-penetrant dopamine-β-hydroxylase inhibitors
|
EP17778369.3A
EP3515433A1
(en)
|
2016-09-23 |
2017-09-22 |
Blood-brain barrier-penetrant dopamine-b-hydroxylase inhibitors
|
PE2019000690A
PE20190964A1
(en)
|
2016-09-23 |
2017-09-22 |
DOPAMINE-B-HYDROXYLASE PENETRANT INHIBITORS OF THE HEMATOENCEPHALIC BARRIER
|
EP17787270.2A
EP3515917A1
(en)
|
2016-09-23 |
2017-09-22 |
Dopamine-b-hydroxylase inhibitors
|
TW106132670A
TWI746644B
(en)
|
2016-09-23 |
2017-09-22 |
DOPAMINE-β-HYDROXYLASE INHIBITORS
|
CA3036650A
CA3036650A1
(en)
|
2016-09-23 |
2017-09-22 |
Dopamine-b-hydroxylase inhibitors
|
PE2019000691A
PE20191103A1
(en)
|
2016-09-23 |
2017-09-22 |
DOPAMINE-B-HYDROXYLASE INHIBITORS
|
KR1020197011658A
KR20190076967A
(en)
|
2016-09-23 |
2017-09-22 |
Dopamine-beta -hydroxylase inhibitor
|
IL265138A
IL265138B
(en)
|
2016-09-23 |
2019-03-03 |
Blood-brain barrier-penetrant dopamine-b-hydroxylase inhibitors
|
IL265139A
IL265139B
(en)
|
2016-09-23 |
2019-03-03 |
Dopamine-b-hydroxylase inhibitors
|
CL2019000662A
CL2019000662A1
(en)
|
2016-09-23 |
2019-03-14 |
Dopamine-b-hydroxylase inhibitors.
|
CL2019000661A
CL2019000661A1
(en)
|
2016-09-23 |
2019-03-14 |
Dopamine-b-hydroxylase inhibitors penetrating the blood brain barrier.
|
PH12019500569A
PH12019500569A1
(en)
|
2016-09-23 |
2019-03-15 |
Blood-brain barrier-penetrant dopamine-b-hydroxylase inhibitors
|
PH12019500568A
PH12019500568A1
(en)
|
2016-09-23 |
2019-03-15 |
Dopamine-b-hydroxylase inhibitors
|
CONC2019/0002523A
CO2019002523A2
(en)
|
2016-09-23 |
2019-03-18 |
Dopamine-β-hydroxylase inhibitors of the blood-brain barrier
|
CONC2019/0002517A
CO2019002517A2
(en)
|
2016-09-23 |
2019-03-18 |
Dopamine-β-hydroxylase inhibitors
|
US17/198,606
US20220017523A1
(en)
|
2016-09-23 |
2021-03-11 |
BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-ß-HYDROXYLASE INHIBITORS
|